Navigation Links
Chem Rx Corporation Reports Full Year 2007 Financial Results
Date:4/3/2008

- Conference Call Scheduled Friday, April 4, 2008 at 8:30 a.m. EDT -

Recent Highlights: - 2007 pro forma consolidated net sales increased 21.2% year-over-year to

$317.2 million - Provided 2008 guidance: revenue of $360 million to $370 million; EBITDA

of $28 million to $30 million - Net beds served increased 21% year-over-year to 63,800 at year-end 2007 - Established pharmacy operations center in Deerfield Beach, Florida;

commenced operation on April 1, 2008

- Completed expansion of South Plainfield, New Jersey facility - Filed application for the listing of its common stock on NASDAQ Capital

Market

LONG BEACH, N.Y., April 3, 2008 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: PMQC, PMQCU, PMQCW), a leading provider of institutional pharmacy services, today reported financial results for the year ended December 31, 2007.

The Company was formed in 2005 as a blank check company under the name Paramount Acquisition Corp. Until October 26, 2007, the Company had no employees and no operating assets, and its sole purpose was to seek to complete the acquisition of a business or entity in the health care industry. On October 26, 2007, the Company completed its initial business combination transaction pursuant to which it acquired B.J.K. Inc., which conducts business under the name "Chem Rx." In conjunction with that business combination, the Company changed its name to Chem Rx Corporation.

Jerry Silva, Chairman and Chief Executive Officer, commented, "2007 was a transformational year for Chem Rx. We executed on many of our growth initiatives, as evidenced by the 21.2% increase in 2007 net sales to $317.2 million. The higher sales were driven by our 21% growth in net beds as we ended the year servicing over 63,800 residents. Providing high quality service continues to
'/>"/>

SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , HOPKINTON, Mass., July 30 ... reported that for the second quarter of 2009 revenues were $32.1 ... Divestitures and foreign currency translation negatively impacted comparative revenues by ... The Company narrowed its net loss to $4.1 million ($0.08 per ...
... TOKYO, July 30 With a business plan to launch ... subsidiary of,the Zydus group, one of India,s leading integrated pharma ... big boost to its operations,in the Japanese generic market which ... estimated at $ 60 bn the generic market is only,about ...
... PLEASANTON, Calif., FRAMINGHAM, Mass. and SYDNEY, ... a world leader in device-based mechanical circulatory support therapies to ... (Nasdaq: HTWR ; ASX: HIN), which develops and ... States Federal Trade Commission ("FTC") has informed them that the ...
Cached Biology Technology:Caliper Life Sciences Reports Second Quarter 2009 Results 2Caliper Life Sciences Reports Second Quarter 2009 Results 3Caliper Life Sciences Reports Second Quarter 2009 Results 4Caliper Life Sciences Reports Second Quarter 2009 Results 5Caliper Life Sciences Reports Second Quarter 2009 Results 6Caliper Life Sciences Reports Second Quarter 2009 Results 7Caliper Life Sciences Reports Second Quarter 2009 Results 8Caliper Life Sciences Reports Second Quarter 2009 Results 9Caliper Life Sciences Reports Second Quarter 2009 Results 10"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 4
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... Respiratory syncytial virus (RSV) infection is a widespread infant illness ... but may be curable by the development of this new ... and The University of Queensland's Faculty of Biological and Chemical ... cost millions of dollars a year in health care in ...
... by just 1.2 percent, yet there is a considerable difference ... A new study showed that a certain form of neuropsin, ... is expressed only in the central nervous systems of humans ... The study, which also demonstrated the molecular mechanism that creates ...
... immune system component that is a primary cause of ... rheumatoid arthritis actually protects bone in the oral cavity ... periodontal disease in humans, research at the University at ... only in the past 18 months to be a ...
Cached Biology News:UQ research heralds vaccine technology breakthrough 2Gene mutation linked to cognition is found only in humans 2Molecule that destroys bone also protects it, new research shows 2Molecule that destroys bone also protects it, new research shows 3
Human Cell Line Slides...
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Biology Products: